한국어 
日本語 
English 
Background — Small Pharmaceutical Company
MRs must master vast detailing materials with each new drug launch — mechanisms of action, clinical data, competitive differentiation, prescribing guidelines. They must absorb and accurately deliver this information to physicians. Classroom training required MRs to leave the field, and training lagged behind the pace of new drug launches.
Solution — Small Pharmaceutical Company
Designed lunchtime new drug detailing sessions as under-5-minute microlearning. Key drug information was delivered via card news and short-form videos for quick review before hospital visits. Push notifications on content upload drove immediate engagement.
Results — Small Pharmaceutical Company
Achieved 95% MAU. Participation spiked at each content upload — a pattern consistently observed across P1 companies, confirming a strong positive correlation between content supply and engagement. Even as a small organization, 95% MAU was possible because the "reason to log in" was directly tied to daily work.
Insight — Small Pharmaceutical Company
A mid-sized pharma achieving ~95% MAU (lunchtime microlearning + monthly tests) and this smaller pharma's 95% MAU (lunchtime new-drug detailing) share the same pattern. The pharma/medical sector has a 12-month MAU median of 38% (Q1 18%, Q3 72%) — the second-highest industry group after franchise/foodservice — driven by ongoing product-training demand and the effectiveness of lunchtime learning.
